{"filing":{"accession_number":"0001193125-26-235401","cik":"0000791908","ticker":"XOMAP","company_name":"XOMA Royalty Corp","form":"8-K","filing_date":"2026-05-22","report_date":null,"primary_document":"d143329d8k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/791908/000119312526235401/d143329d8k.htm"},"events":[{"id":10533,"run_id":9237,"accession_number":"0001193125-26-235401","anchor_item_number":"5.07","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"summary":"XOMA Royalty Corp held its 2026 Annual Meeting of Stockholders on May 21, 2026, where stockholders approved five proposals: election of seven directors, ratification of Deloitte \u0026 Touche LLP as independent auditor, amendment and restatement of the 2010 Long Term Incentive and Stock Award Plan (increasing available shares by 425,000 and extending the term to 2036), approval of the 2026 Employee Stock Purchase Plan (500,000 shares available), and advisory approval of named executive officer compensation. All proposals passed with substantial majorities.","company_name":"XOMA Royalty Corp","ticker":"XOMAP","filing_date":"2026-05-22","form":"8-K","submitted_at":null,"items":[{"id":6865,"accession_number":"0001193125-26-235401","item_number":"5.02","item_title":null,"event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.92,"reasoning":"The filing discloses results of the 2026 Annual Meeting of Stockholders held on May 21, 2026, where stockholders approved two proposals: an amendment and restatement of the 2010 Long Term Incentive and Stock Award Plan (increasing available shares by 425,000 and extending the term to 2036) and approval of the 2026 Employee Stock Purchase Plan (500,000 shares available). This is a classic shareholder vote results disclosure under Item 5.07, material because it affects equity compensation structure and dilution potential.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-13T00:26:32.825830+00:00","company_name":"","ticker":null,"filing_date":""},{"id":6867,"accession_number":"0001193125-26-235401","item_number":"5.07","item_title":null,"event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"reasoning":"This is a standard Item 5.07 disclosure of shareholder meeting voting results. The filing reports the final vote tallies for five proposals at the Annual Meeting: election of seven directors (all approved), ratification of Deloitte \u0026 Touche LLP as independent auditor (approved), amendment and restatement of the 2010 Long Term Incentive and Stock Award Plan (approved), approval of the 2026 Employee Stock Purchase Plan (approved), and advisory approval of named executive officer compensation (approved). All proposals passed with substantial majorities, making this a routine but material governance disclosure.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-13T00:26:32.825830+00:00","company_name":"","ticker":null,"filing_date":""}]},{"id":10534,"run_id":9237,"accession_number":"0001193125-26-235401","anchor_item_number":"5.03","event_type":"other_material","event_domain":"catchall","is_material":true,"confidence":0.65,"summary":"The company adopted bylaw amendments in connection with a pending merger with Ligand Pharmaceuticals, including provisions related to Nevada controlling interest statutes and exclusive forum selection that affect shareholder rights and dispute resolution procedures.","company_name":"XOMA Royalty Corp","ticker":"XOMAP","filing_date":"2026-05-22","form":"8-K","submitted_at":null,"items":[{"id":6866,"accession_number":"0001193125-26-235401","item_number":"5.03","item_title":null,"event_type":"other_material","event_domain":"catchall","is_material":true,"confidence":0.65,"reasoning":"The filing discloses bylaw amendments adopted in connection with a pending merger with Ligand Pharmaceuticals. While bylaw amendments are typically routine administrative matters, these amendments are material because they are directly tied to a material M\u0026A transaction and include substantive provisions (Nevada controlling interest statutes and exclusive forum selection) that affect shareholder rights and dispute resolution. The amendments do not fit neatly into the specific event taxonomy, making \"other_material\" the most appropriate classification.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-13T00:26:32.825830+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":6865,"accession_number":"0001193125-26-235401","item_number":"5.02","item_title":null,"event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.92,"reasoning":"The filing discloses results of the 2026 Annual Meeting of Stockholders held on May 21, 2026, where stockholders approved two proposals: an amendment and restatement of the 2010 Long Term Incentive and Stock Award Plan (increasing available shares by 425,000 and extending the term to 2036) and approval of the 2026 Employee Stock Purchase Plan (500,000 shares available). This is a classic shareholder vote results disclosure under Item 5.07, material because it affects equity compensation structure and dilution potential.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-13T00:26:32.825830+00:00","company_name":"XOMA Royalty Corp","ticker":"XOMAP","filing_date":"2026-05-22"},{"id":6866,"accession_number":"0001193125-26-235401","item_number":"5.03","item_title":null,"event_type":"other_material","event_domain":"catchall","is_material":true,"confidence":0.65,"reasoning":"The filing discloses bylaw amendments adopted in connection with a pending merger with Ligand Pharmaceuticals. While bylaw amendments are typically routine administrative matters, these amendments are material because they are directly tied to a material M\u0026A transaction and include substantive provisions (Nevada controlling interest statutes and exclusive forum selection) that affect shareholder rights and dispute resolution. The amendments do not fit neatly into the specific event taxonomy, making \"other_material\" the most appropriate classification.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-13T00:26:32.825830+00:00","company_name":"XOMA Royalty Corp","ticker":"XOMAP","filing_date":"2026-05-22"},{"id":6867,"accession_number":"0001193125-26-235401","item_number":"5.07","item_title":null,"event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"reasoning":"This is a standard Item 5.07 disclosure of shareholder meeting voting results. The filing reports the final vote tallies for five proposals at the Annual Meeting: election of seven directors (all approved), ratification of Deloitte \u0026 Touche LLP as independent auditor (approved), amendment and restatement of the 2010 Long Term Incentive and Stock Award Plan (approved), approval of the 2026 Employee Stock Purchase Plan (approved), and advisory approval of named executive officer compensation (approved). All proposals passed with substantial majorities, making this a routine but material governance disclosure.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-13T00:26:32.825830+00:00","company_name":"XOMA Royalty Corp","ticker":"XOMAP","filing_date":"2026-05-22"}]}